Latest filing published 05 Aug 2025 for Prime Medicine, Inc., €4.3M.
Filing timeline
BuySaleInsider track record
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
GV 2021 GP, L.L.C.: trading record in brief
Filings by GV 2021 GP, L.L.C. span 2 companies, the busiest being Gitlab Inc. and Prime Medicine, Inc. The record holds 33 filings, for trades running from 10 May 2022 to 1 August 2025.
Purchases make up the whole of the open-market record (33 purchases, €77.1M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 1 purchase and no sales on the market.
The median purchase comes to €2.3M. Of 33 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 5 August 2025 with an open-market purchase (€4.3M) in Prime Medicine, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to GV 2021 GP, L.L.C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500,000 shares@ US$3.30100.0% of flowCommon StockSEC:0001415889-25-021025:0Canonical exit: 30 Oct 2025 (T+90)
- 7,286 shares@ US$26.9810.6% of flowClass A Common StockSEC:0001209191-23-028245:0Canonical exit: 3 Aug 2023 (T+90)
- 287,470 shares@ US$28.295222.9% of flowClass A Common StockSEC:0001209191-23-027711:0Canonical exit: 1 Aug 2023 (T+90)
- 119,798 shares@ US$28.25549.9% of flowClass A Common StockSEC:0001209191-23-018969:0Canonical exit: 11 Jun 2023 (T+90)
- 14,264 shares@ US$35.96631.6% of flowClass A Common StockSEC:0001209191-22-056458:0Canonical exit: 6 Feb 2023 (T+90)
- 121,424 shares@ US$35.525713.8% of flowClass A Common StockSEC:0001209191-22-056129:0Canonical exit: 2 Feb 2023 (T+90)
- 141,028 shares@ US$36.289916.3% of flowClass A Common StockSEC:0001209191-22-056129:1Canonical exit: 2 Feb 2023 (T+90)
- 15,041 shares@ US$37.21111.8% of flowClass A Common StockSEC:0001209191-22-056129:2Canonical exit: 2 Feb 2023 (T+90)
- 136,376 shares@ US$34.905614.9% of flowClass A Common StockSEC:0001209191-22-056129:3Canonical exit: 5 Feb 2023 (T+90)
- 65,421 shares@ US$35.697.3% of flowClass A Common StockSEC:0001209191-22-056129:4Canonical exit: 5 Feb 2023 (T+90)
- 100 shares@ US$36.410.0% of flowClass A Common StockSEC:0001209191-22-056129:5Canonical exit: 5 Feb 2023 (T+90)
- 13,528 shares@ US$33.71891.3% of flowClass A Common StockSEC:0001209191-22-031962:0Canonical exit: 22 Aug 2022 (T+90)
- 14,860 shares@ US$32.96361.5% of flowClass A Common StockSEC:0001209191-22-029127:0Canonical exit: 10 Aug 2022 (T+90)
- 82,055 shares@ US$33.71848.2% of flowClass A Common StockSEC:0001209191-22-028641:0Canonical exit: 8 Aug 2022 (T+90)
14 of 14 declarations
